FilingReader Intelligence
Mitsubishi Chemical to transfer pharma business in company split
March 31, 2025 at 09:01 AM UTC•By FilingReader AI
Mitsubishi Chemical Group Corporation (TSE:4188) announced the planned transfer of its consolidated subsidiary, Mitsubishi Tanabe Pharma Corporation (MTPC), to a special purpose company under the umbrella of K.K. BCJ-94, indirectly owned by an investment fund advised by Bain Capital Private Equity. The transfer will be executed through a company split, with Mitsubishi Chemical as the splitting company and K.K. BCJ-94 as the successor.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
TSE:4188•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Mitsubishi Chemical Holdings Corporation publishes news
Free account required • Unsubscribe anytime